| Activation of programmed cell death in the rat ventral prostate after castration N Kyprianou, JT Isaacs Endocrinology 122 (2), 552-562, 1988 | 909 | 1988 |
| Programmed cell death during regression of PC-82 human prostate cancer following androgen ablation N Kyprianou, HF English, JT Isaacs Cancer research 50 (12), 3748-3753, 1990 | 661 | 1990 |
| Programmed cell death during regression of the MCF-7 human breast cancer following estrogen ablation N Kyprianou, HF English, NE Davidson, JT Isaacs Cancer research 51 (1), 162-166, 1991 | 549 | 1991 |
| Expression of transforming growth factor-β in the rat ventral prostate during castration-induced programmed cell death N Kyprianou, JT Isaacs Molecular Endocrinology 3 (10), 1515-1522, 1989 | 531 | 1989 |
| Homozygous deletion and frequent allelic loss of chromosome 8p22 loci in human prostate cancer GS Bova, BS Carter, MJG Bussemakers, M Emi, Y Fujiwara, N Kyprianou, ... Cancer research 53 (17), 3869-3873, 1993 | 498 | 1993 |
| Tubulin-targeting chemotherapy impairs androgen receptor activity in prostate cancer ML Zhu, CM Horbinski, M Garzotto, DZ Qian, TM Beer, N Kyprianou Cancer research 70 (20), 7992-8002, 2010 | 414 | 2010 |
| Androgen receptor and growth factor signaling cross-talk in prostate cancer cells ML Zhu, N Kyprianou Endocr Relat Cancer 15 (4), 841-849, 2008 | 368 | 2008 |
| Caspase control: protagonists of cancer cell apoptosis MV Fiandalo, N Kyprianou Experimental oncology 34 (3), 165, 2012 | 361 | 2012 |
| Relationship between DNA fragmentation and apoptosis in the programmed cell death in the rat prostate following castration HF English, N Kyprianou, JT Isaacs The Prostate 15 (3), 233-250, 1989 | 331 | 1989 |
| Apoptotic versus proliferative activities in human benign prostatic hyperplasia N Kyprianou, H Tu, SC Jacobs Human pathology 27 (7), 668-675, 1996 | 327 | 1996 |
| Loss of caspase-1 and caspase-3 protein expression in human prostate cancer RN Winter, A Kramer, A Borkowski, N Kyprianou Cancer research 61 (3), 1227-1232, 2001 | 311 | 2001 |
| Effect of Transforming Growth Factor-β1 on Proliferation and Death of Rat Prostatic Cells P Martikainen, N Kyprianou, JT Isaacs Endocrinology 127 (6), 2963-2968, 1990 | 272 | 1990 |
| bcl-2/bax ratio as a predictive marker for therapeutic response to radiotherapy in patients with prostate cancer TJ Mackey, A Borkowski, P Amin, SC Jacobs, N Kyprianou Urology 52 (6), 1085-1090, 1998 | 267 | 1998 |
| Loss of the cyclin-dependent kinase inhibitor p27 (Kip1) protein in human prostate cancer correlates with tumor grade. Y Guo, GN Sklar, A Borkowski, N Kyprianou Clinical cancer research: an official journal of the American Association …, 1997 | 267 | 1997 |
| Role of androgens and the androgen receptor in epithelial-mesenchymal transition and invasion of prostate cancer cells ML Zhu, N Kyprianou The FASEB Journal 24 (3), 769, 2010 | 265 | 2010 |
| Talin1 promotes tumor invasion and metastasis via focal adhesion signaling and anoikis resistance S Sakamoto, RO McCann, R Dhir, N Kyprianou Cancer research 70 (5), 1885-1895, 2010 | 261 | 2010 |
| Activation of a Ca2+−Mg2+‐dependent endonuclease as an early event in castration‐induced prostatic cell death N Kyprianou, HF English, JT Isaacs The Prostate 13 (2), 103-117, 1988 | 228 | 1988 |
| Programmed death of nonproliferating androgen-independent prostatic cancer cells P Martikainen, N Kyprianou, RW Tucker, JT Isaacs Cancer research 51 (17), 4693-4700, 1991 | 218 | 1991 |
| Identification of a cellular receptor for transforming growth factor-β in rat ventral prostate and its negative regulation by androgens N Kyprianou, JT Isaacs Endocrinology 123 (4), 2124-2131, 1988 | 217 | 1988 |
| Androgen regulation of programmed death of normal and malignant prostatic cells JT ISAACS, PERI LUNDMO, R BERGES, P MARTIKAINEN, ... Journal of andrology 13 (6), 457-464, 1992 | 216 | 1992 |
